Amanta Healthcare Ltd

NSE: AMANTA BSE: 544502Pharma

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]

₹126

52W: ₹92 — ₹155

PE 30.6 · Book ₹54.3 · +132% vs book

Market Cap₹490 Cr

Stock P/E30.6Price to Earnings

ROCE14.8%Return on Capital

ROE13%Return on Equity

Div. Yield0%Face Value ₹10

Strengths

+Company has delivered good profit growth of 20.7% CAGR over last 5 years

Weaknesses

−Though the company is reporting repeated profits, it is not paying out dividend
−The company has delivered a poor sales growth of 8.30% over past five years.
−Company has a low return on equity of 5.80% over last 3 years.

Shareholding Pattern

Promoters63.72%

FIIs0.85%

DIIs12.88%

Public22.55%

Category	Sep 2025	Dec 2025	Mar 2026
Promoters	63.56%	63.56%	63.72%▲0.2
FIIs	1%	1.1%▲0.1	0.85%▼0.3
DIIs	11.34%	11.24%▼0.1	12.88%▲1.6
Public	24.1%	24.09%▼0.0	22.55%▼1.5

Financial Statements

Metric	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	68.1	66.73	67.81	72.06	65.31	70.89	74.49
Expenses	54.7	52.85	52.75	53.1	50.41	56.24	59.13
Operating Profit	13.4	13.88	15.06	18.96	14.9	14.65	15.36
OPM %	19.68%	20.8%	22.21%	26.31%	22.81%	20.67%	20.62%
Net Profit	-0.36	2.26	4.28	5.96	3.51	1.21	4.63
EPS ₹	-0.13	0.78	1.48	2.07	1.22	0.31	1.19

AI Insights

Revenue Trend

TTM revenue at ₹283Cr, up 2.9% YoY. OPM at 23%.

Debt Position

Borrowings at ₹186Cr. Debt-to-equity ratio: 1.08x. High leverage — monitor closely.

Capex Cycle

CWIP at ₹11Cr (5% of fixed assets). Moderate ongoing capital expenditure.

Margin & Efficiency

ROCE improving from 0% (Mar 2020) to 15% (Mar 2025). Working capital days: 26.

Valuation

PE 30.6x with 14.8% ROCE. Price is 132% above book value of ₹54.3. Dividend yield: 0%.